Loading clinical trials...
Loading clinical trials...
Comparison of Efficacy of Low Glycemic Index Therapy and Modified Atkins Diet Among Children With Drug Resistant Epilepsy: A Randomized Non-inferiority Trial
To compare the efficacy of two less restrictive dietary therapies - LGIT and MAD, used for treatment of drug resistant epilepsy in children
Up to one third of patients with epilepsy progress to drug resistant epilepsy (DRE). Current treatment options for DRE include epileptic surgery and dietary therapy. Classic KD (Ketogenic diet) is the most studied dietary therapy but the stringent restrictions and practical difficulty makes it difficult to follow. So less restrictive diets like MAD and LGIT were introduced. These are reported to have less adverse effects also. But no published study has ever been conducted comparing these two diets head to head.
Age
1 - 15 years
Sex
ALL
Healthy Volunteers
No
All India Institute of Medical Sciences
New Delhi, National Capital Territory of Delhi, India
AIIMS
New Delhi, National Capital Territory of Delhi, India
Start Date
December 26, 2018
Primary Completion Date
December 1, 2019
Completion Date
December 1, 2019
Last Updated
September 10, 2019
110
ESTIMATED participants
Low glycemic Index Therapy (LGIT)
OTHER
Modified Atkins Diet (MAD)
OTHER
Lead Sponsor
All India Institute of Medical Sciences
NCT03268824
NCT05019885
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions